tetano
Editor, Senior Moderator
J Oral Microbiol
. 2021 Apr 30;13(1):1920226.
doi: 10.1080/20002297.2021.1920226.
Salivette, a relevant saliva sampling device for SARS-CoV-2 detection
Monique Melo Costa[SUP] 1 2 3 [/SUP], Nicolas Benoit[SUP] 1 2 3 4 [/SUP], Jerome Dormoi[SUP] 1 2 3 [/SUP], Remy Amalvict[SUP] 1 2 3 4 [/SUP], Nicolas Gomez[SUP] 1 2 3 [/SUP], Herv? Tissot-Dupont[SUP] 2 3 [/SUP], Matthieu Million[SUP] 2 3 [/SUP], Bruno Pradines[SUP] 1 2 3 4 [/SUP], Samuel Granjeaud[SUP] 5 [/SUP], Lionel Almeras[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
Background: The gold standard for COVID-19 diagnosis relies on quantitative reverse-transcriptase polymerase-chain reaction (RT-qPCR) from nasopharyngeal swab (NPS) specimens, but NPSs present several limitations. The simplicity, low invasive and possibility of self-collection of saliva imposed these specimens as a relevant alternative for SARS-CoV-2 detection. However, the discrepancy of saliva test results compared to NPSs made of its use controversial. Here, we assessed Salivettes?, as a standardized saliva collection device, and compared SARS-CoV-2 positivity on paired NPS and saliva specimens. Methods: A total of 303 individuals randomly selected among those investigated for SARS-CoV-2 were enrolled, including 30 (9.9%) patients previously positively tested using NPS (follow-up group), 90 (29.7%) mildly symptomatic and 183 (60.4%) asymptomatic. Results: The RT-qPCR revealed a positive rate of 11.6% (n = 35) and 17.2% (n = 52) for NPSs and saliva samples, respectively. The sensitivity and specificity of saliva samples were 82.9% and 91.4%, respectively, using NPS as reference. The highest proportion of discordant results concerned the follow-up group (33.3%). Although the agreement exceeded 90.0% in the symptomatic and asymptomatic groups, 17 individuals were detected positive only in saliva samples, with consistent medical arguments. Conclusion Saliva collected with Salivette? was more sensitive for detecting symptomatic and pre-symptomatic infections.
Keywords: COVID-19 diagnosis; SARS-CoV-2; Saliva; coronavirus.
. 2021 Apr 30;13(1):1920226.
doi: 10.1080/20002297.2021.1920226.
Salivette, a relevant saliva sampling device for SARS-CoV-2 detection
Monique Melo Costa[SUP] 1 2 3 [/SUP], Nicolas Benoit[SUP] 1 2 3 4 [/SUP], Jerome Dormoi[SUP] 1 2 3 [/SUP], Remy Amalvict[SUP] 1 2 3 4 [/SUP], Nicolas Gomez[SUP] 1 2 3 [/SUP], Herv? Tissot-Dupont[SUP] 2 3 [/SUP], Matthieu Million[SUP] 2 3 [/SUP], Bruno Pradines[SUP] 1 2 3 4 [/SUP], Samuel Granjeaud[SUP] 5 [/SUP], Lionel Almeras[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 33986939
- PMCID: PMC8098750
- DOI: 10.1080/20002297.2021.1920226
Abstract
Background: The gold standard for COVID-19 diagnosis relies on quantitative reverse-transcriptase polymerase-chain reaction (RT-qPCR) from nasopharyngeal swab (NPS) specimens, but NPSs present several limitations. The simplicity, low invasive and possibility of self-collection of saliva imposed these specimens as a relevant alternative for SARS-CoV-2 detection. However, the discrepancy of saliva test results compared to NPSs made of its use controversial. Here, we assessed Salivettes?, as a standardized saliva collection device, and compared SARS-CoV-2 positivity on paired NPS and saliva specimens. Methods: A total of 303 individuals randomly selected among those investigated for SARS-CoV-2 were enrolled, including 30 (9.9%) patients previously positively tested using NPS (follow-up group), 90 (29.7%) mildly symptomatic and 183 (60.4%) asymptomatic. Results: The RT-qPCR revealed a positive rate of 11.6% (n = 35) and 17.2% (n = 52) for NPSs and saliva samples, respectively. The sensitivity and specificity of saliva samples were 82.9% and 91.4%, respectively, using NPS as reference. The highest proportion of discordant results concerned the follow-up group (33.3%). Although the agreement exceeded 90.0% in the symptomatic and asymptomatic groups, 17 individuals were detected positive only in saliva samples, with consistent medical arguments. Conclusion Saliva collected with Salivette? was more sensitive for detecting symptomatic and pre-symptomatic infections.
Keywords: COVID-19 diagnosis; SARS-CoV-2; Saliva; coronavirus.